1. Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

   • Khalid M. Kamal
   • Shane P. Desselle
   • Christopher Zacker

   Regulatory Affairs 30 December 2009 Pages: 385 - 393

2. Electronic Common Technical Document Implementation in Japan

   • Kiyohito Nakai
   • Yasuhiro Araki
   • Satoshi Toyoshima

   Regulatory Affairs 30 December 2009 Pages: 395 - 401

3. Editorial: Dealing with the Missing Data Challenge in Clinical Trials

   • Thomas Permutt
   • José Pinheiro

   Data Management — Missing Data 30 December 2009 Pages: 403 - 408

4. Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis

   • Geert Molenberghs

   Data Management — Missing Data 30 December 2009 Pages: 409 - 429

5. Comment: Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis

   • Joseph G. Ibrahim

   Data Management — Missing Data 30 December 2009 Pages: 431 - 432

6. A Commentary on G. Molenberghs’s Review of Missing Data Methods

   • Eric J. Tchetgen Tchetgen

   Data Management — Missing Data 30 December 2009 Pages: 433 - 435

7. Discussion: “Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis” by Geert Molenberghs

   • Paul A. Flyer

   Data Management — Missing Data 30 December 2009 Pages: 437 - 439

8. Global Sensitivity Analysis for Randomized Trials with Informative Dropout: A Semiparametric Perspective

   • Daniel O. Scharfstein
   • Aristide Achy-Brou

   Data Management — Missing Data 30 December 2009 Pages: 441 - 446

9. Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis—Rejoinder

   • Geert Molenberghs

   Data Management — Missing Data 30 December 2009 Pages: 447 - 448

10. Conceptual Considerations regarding Endpoints, Hypotheses, and Analyses for Incomplete Longitudinal Clinical Trial Data

    • Craig H. Mallinckrodt
    • Michael G. Kenward

    Data Management — Missing Data 30 December 2009 Pages: 449 - 458

11. Effective Strategies for Maintaining Research Participation in Clinical Trials

    • Allen Zweben
    • Lisa M. Fucito
    • Stephanie S. O’Malley

    Data Management — Missing Data 30 December 2009 Pages: 459 - 467

12. A Note on Missing Data in Noninferiority Trials

    • Paul Gallo
    • Christy Chuang-Steiny

    Data Management — Missing Data 30 December 2009 Pages: 469 - 474

13. Sensitivity Analysis of Missing Data: Case Studies Using Model-Based Multiple Imputation

    • Jie Zhang

    Data Management — Missing Data 30 December 2009 Pages: 475 - 484

14. Minimizing Missing Data in Clinical Trials: Design, Operation, and Regulatory Considerations

    • Guoxing (Greg) Soon

    Data Management — Missing Data 30 December 2009 Pages: 485 - 492

15. Drug Development Portfolio and Spending Practices after Mergers and Acquisitions

    • Kenneth A. Getz
    • Rachael Zuckerman
    • Kenneth I. Kaitin

    Drug Development: Continuing Education 30 December 2009 Pages: 493 - 500

16. Bringing Patient Recruitment into Our Digital World

    • John D. McAnulty

    Drug Development 30 December 2009 Pages: 501 - 508

17. Assessing Medical Information Needs via an Internet-Based Survey

    • Stacey M. Fung
    • Laura Merriman
    • Maureen Cawley

    Drug Information 30 December 2009 Pages: 509 - 518

18. 2009 Annual Meeting Student Poster Abstracts

    • Springer

    Annual Meeting 30 December 2009 Pages: 519 - 524